Compare RUSHB & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUSHB | PRAX |
|---|---|---|
| Founded | 1965 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.1B |
| IPO Year | 1996 | 2020 |
| Metric | RUSHB | PRAX |
|---|---|---|
| Price | $79.82 | $369.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $572.13 |
| AVG Volume (30 Days) | 88.6K | ★ 380.0K |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.68 | N/A |
| Revenue | ★ $7,434,195,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.44 | $7,758.26 |
| P/E Ratio | $46.82 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $47.71 | $37.25 |
| 52 Week High | $81.52 | $386.66 |
| Indicator | RUSHB | PRAX |
|---|---|---|
| Relative Strength Index (RSI) | 60.97 | 63.13 |
| Support Level | $73.26 | $285.26 |
| Resistance Level | $81.52 | N/A |
| Average True Range (ATR) | 2.23 | 18.47 |
| MACD | -0.03 | 7.02 |
| Stochastic Oscillator | 82.57 | 83.40 |
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.